Zobrazeno 1 - 10
of 708
pro vyhledávání: '"Myeloma cell"'
Autor:
Mochamad Lazuardi, Suharjono Suharjono, Chi-Hsien Chien, Jie-Long He, Chi-Wen Lee, Chia-Kang Peng, Mohammad Sukmanadi, Rahmi Sugihartuti, Lilik Maslachah
Publikováno v:
Veterinary World, Vol 15, Iss 12, Pp 2896-2902 (2022)
Background and Aim: The flavonoids from mistletoe are thought to have antimicrobial action. This encouraging finding supports the benefits of medicinal plants as a substitute for synthetic antimicrobials, thus promoting healthy lifestyles. In contras
Externí odkaz:
https://doaj.org/article/a07a76eedd47470cbdefbedd2c5e3d20
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Liang Zhou
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Antiproliferation and proapoptosis are two major molecular mechanisms of action of drugs used for the treatment of multiple myeloma. Proteasome inhibitors, such as bortezomib (PS-341), and immunomodulatory drugs (IMiDs), such as lenalidomide, are the
Externí odkaz:
https://doaj.org/article/c6ce415e8e2241b2a1dfcde93b0e76fc
Publikováno v:
Journal of Research in Applied and Basic Medical Sciences, Vol 6, Iss 2, Pp 96-103 (2020)
Cancer stem cells that have the ability to proliferation and self-renewal were cause to drug resistance and metastasis in malignancies. In multiple myeloma, these cancer stem cells (MMCSCs) play a very important role in the recurrence of the disease.
Externí odkaz:
https://doaj.org/article/3a97d987b0cf45ecb569556f8dee47ec
Autor:
Maryam Pourabdollah, Mohammad Bahmanyar, Eshetu G. Atenafu, Donna Reece, Jian Hou, Hong Chang
Publikováno v:
Journal of Hematology & Oncology, Vol 9, Iss 1, Pp 1-4 (2016)
Abstract The aim of this study is to assess nucleoprotein expression of IKZF1/3 in patients with relapsed/refractory multiple myeloma (MM) who received lenalidomide-based therapy and correlated them with their clinical outcomes. A total of 50 patient
Externí odkaz:
https://doaj.org/article/dfa8b7b9b7824031901fa9aca7c35de6
Publikováno v:
Current Oncology, Vol 28, Iss 193, Pp 2087-2096 (2021)
Current Oncology
Current Oncology
Multiple myeloma (MM) is a malignant disease of the plasma cells representing approximately 10% of all hemato-oncological diseases. Detection of the disease is most probable at around 65 years of age, and the average survival of patients is estimated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dca8cb9fe2ed23ad5133b6e1ea7619ba
https://www.mdpi.com/1718-7729/28/3/193
https://www.mdpi.com/1718-7729/28/3/193
Publikováno v:
Indonesian Journal of Biotechnology, Vol 19, Iss 1, Pp 23-32 (2014)
Cancer is a disease, a public health problem, which is found in the world as well as in Indonesia. In general, some of cancer theraphies are ineffective, characterized by the resistance performance of cancer cell line, the exposed normal cell and by
Externí odkaz:
https://doaj.org/article/2404e798cae740119c7151c5794c620e
Publikováno v:
BMC Bioinformatics, Vol 22, Iss 1, Pp 1-12 (2021)
BMC Bioinformatics
BMC Bioinformatics
Background tRNA-derived fragments have been reported to be key regulatory factors in human tumors. However, their roles in the progression of multiple myeloma remain unknown. Results This study employed RNA-sequencing to explore the expression profil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8f5fdd57da5197d10cfe36f1d1f8490
https://doaj.org/article/97e6bce73a1a4a53baae8d6d6689b0ca
https://doaj.org/article/97e6bce73a1a4a53baae8d6d6689b0ca
Publikováno v:
Plasma Medicine. 11:15-30
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd08291d5d7f6ff010a766aa1053a850
https://doi.org/10.1615/plasmamed.2021040378
https://doi.org/10.1615/plasmamed.2021040378
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.